Patent Assignment
Reel/Frame 057310/0385
Security Interest
Recorded: 2021-08-27
Pages: 11
Assignors
AVION PHARMACEUTICALS, LLC
Executed: 2021-08-27
SOVEREIGN PHARMACEUTICALS, LLC
Executed: 2021-08-27
ACELLA HOLDINGS, LLC
Executed: 2021-08-27
Assignee
CIBC BANK USA, AS ADMINISTRATIVE AGENT
3290 NORTHSIDE PARKWAY NW, 7TH FLOOR, ATLANTA, GEORGIA, 30327
Covered Properties
(28)
Osmotic Device Having a Preformed Passageway That Increases in Size
Drug Delivery Device Containing Oseltamivir and an H1 Antagonist
Laser Drilling System and Method
Oral Composition and Method for the Treatment of Inflammatory Cutaneous Disorders
Patent:
6,979,468 →
Application:
10/313,165 →
Osmotic Device Containing Venlafaxine and an Anti-Psychotic Agent
Drug Delivery Device Containing Neuraminidase Inhibitor and an H1 Antagonist
Laser Drilling System and Method
Osmotic Device Containing a Venlafaxine Salt and a Salt Having an Ion in Common
Dosage form containing diphenhydramine and another drug
Dual Controlled Release Osmotic Device
Triple Combination Release Multi-Layered Tablet
Rupturing Controlled Release Device Comprising a Subcoat
Dual Controlled Release Dosage Form
Triple Combination Release Multi-layered Tablet
Immediate Release Oral Guaifenesin Solution
Patent:
9,549,907 →
Application:
14/940,455 →
Immediate Release Oral Guaifenesin Solution
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,707,217 →
Application:
15/424,134 →
System for Upper Intestinal Delivery of Active Ingredients
Application:
15/472,552 →
Publication:
US 2017/0281554
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,827,234 →
Application:
15/624,075 →
Dose-Dumping Resistant Controlled Release Dosage Form
Patent:
9,855,258 →
Application:
15/624,209 →
Dose-Dumping Resistant Controlled Release Dosage Form
Immediate Release Oral Guaifenesin Solution
Dose-Dumping Resistant Controlled Release Dosage Form
Levodopa Fractionated Dose Composition and Use
Levodopa Fractionated Dose Composition and Use
Osmotic Device Having a Preformed Passageway That Increases in Size
Application:
60/177,427 →
Dose-Dumping Resistant Controlled Release Dosage Form
Application:
62/454,269 →
Dose-Dumping Resistant Controlled Release Dosage Form
Application:
62/456,481 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Transfer of Right to Make, Use, Sell, Offer to Sell for Nifedipine
Feb 4, 2010
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 023892/0674 →
Transfer of Right to Make, Use, Sell, Offer to Sell for Oxybutynin
Feb 4, 2010
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 023892/0723 →
Corrective Assignment to Correct the Name of the Assignee on the Recordation Sheet to Osmotica Pharmaceutical Corp. Previously Recorded on Reel 023892 Frame 0674. Assignor(S) Hereby Confirms the Transfer of Right to Make, Use, Sell, Offer to Sell for Nifedipine.
Feb 8, 2010
From: OSMOTICA CORP.
To: OSMOTICA PHARMACEUTICAL CORP.
Reel/Frame 023905/0766 →
Corrective Assignment to Correct the Name of the Assignee on the Recordation Sheet to Osmotica Pharmaceutical Corp. Previously Recorded on Reel 023892 Frame 0723. Assignor(S) Hereby Confirms the Transfer of Right to Make, Use, Sell, Offer to Sell for Oxybutynin.
Feb 8, 2010
From: OSMOTICA CORP.
To: OSMOTICA PHARMACEUTICAL CORP.
Reel/Frame 023905/0752 →
Assignment of Assignor's Interest
Sep 25, 2012
From: VERGEZ, JUAN A; RICCI, MARCELO A
To: OSMOTICA CORP.
Reel/Frame 029019/0275 →
Assignment of Assignor's Interest
Sep 25, 2012
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 029019/0383 →
Assignment of Assignor's Interest
Oct 11, 2012
From: BAYSIDE FINANCE, LLC
To: WHITEHORSE FINANCE WAREHOUSE, LLC
Reel/Frame 029114/0739 →
Release of Security Interest
Sep 18, 2013
From: WHITEHORSE FINANCE WAREHOUSE, LLC
To: ACELLA PHARMACEUTICALS, LLC; NEUVOSYN LABORATORIES, LLC; AVION PHARMACEUTICALS, LLC; ALORA PHARMACEUTICALS, LLC
Reel/Frame 031230/0275 →
Security Agreement
Sep 19, 2013
From: ALORA PHARMACEUTICALS, LLC; ACELLA HOLDINGS, LLC; ACELLA PHARMACEUTICALS, LLC; AVION PHARMACEUTICALS, LLC
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031246/0359 →
Assignee Change of Address
Nov 20, 2013
From: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 031692/0741 →
Assignment of Assignor's Interest
Jun 25, 2014
From: OSMOTICA COSTA RICA SOCIEDAD AUTONIMA
To: OSMOTICA CORP.
Reel/Frame 033227/0577 →
Assignment of Assignor's Interest
Jun 25, 2014
From: TONEGUZZO, FERNANDO G.; MEYER, GLENN A.; RICCI, MARCELO A.; COPPARI, MARCELO A.
To: OSMOTICA COSTA RICA SOCIEDAD AUTONIMA
Reel/Frame 033175/0146 →
Assignment of Assignor's Interest
Jun 25, 2014
From: OSMOTICA CORP.
To: OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KFT
Reel/Frame 033175/0317 →
Assignment of Assignor's Interest
Dec 2, 2015
From: HAFEY, PAUL
To: SOVEREIGN PHARMACEUTICALS, LLC
Reel/Frame 037190/0800 →
Security Interest
Feb 3, 2016
From: OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KORLÁTOLT FELELOSSÉGU TÁRSASÁG
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 037656/0777 →
Security Interest
May 20, 2016
From: ALORA PHARMACEUTICALS, LLC; ACELLA HOLDINGS, LLC; ACELLA PHARMACEUTICALS, LLC; AVION PHARMACEUTICALS, LLC
To: SILVER POINT FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 038656/0234 →
Release of Security Interest
May 24, 2016
From: MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: ALORA PHARMACEUTICALS, LLC; ACELLA HOLDINGS, INC.; ACELLA PHARMACEUTICALS, LLC; AVION PHARMACEUTICALS, LLC
Reel/Frame 038703/0496 →
Assignment of Assignor's Interest
Jul 13, 2016
From: ACELLA PHARMACEUTICALS, LLC
To: AVION PHARMACEUTICALS, LLC
Reel/Frame 039148/0902 →
Assignment of Assignor's Interest
Mar 29, 2017
From: BORTZ, JONATHAN
To: AVION PHARMACEUTICALS, LLC
Reel/Frame 041783/0031 →
Assignment of Assignor's Interest
Jun 29, 2017
From: BENEDETTI, HERNAN D.; FRANCO, CRISTIAN R.; BIGATTI, GUIDO S.; FAOUR, JOAQUINA
To: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
Reel/Frame 043039/0362 →
Release of Security Interest
Dec 27, 2018
From: SILVER POINT FINANCE LLC
To: ALORA PHARMACEUTICALS, LLC; ACELLA HOLDINGS, LLC; ACELLA PHARMACEUTICALS, LLC; AVION PHARMACEUTICALS, LLC
Reel/Frame 047861/0715 →
Security Interest
Dec 28, 2018
From: AVION PHARMACEUTICALS, LLC
To: CIBC BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 047870/0431 →
Security Interest
Jan 3, 2019
From: SOVEREIGN PHARMACEUTICALS, LLC
To: MIDCAP BUSINESS CREDIT LLC
Reel/Frame 047890/0729 →
Release of Intellectual Property Security Interest
Jan 3, 2020
From: MIDCAP BUSINESS CREDIT, LLC
To: SOVEREIGN PHARMACEUTICALS, LLC
Reel/Frame 051463/0377 →
Security Agreement
Jan 6, 2020
From: SOVEREIGN PHARMACEUTICALS, LLC
To: CIBC BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 051485/0571 →